Working… Menu

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02050854
Recruitment Status : Completed
First Posted : January 31, 2014
Last Update Posted : January 31, 2014
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2014
Actual Study Completion Date : January 2014